Pinnacle Summer Investments’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Pinnacle Summer Investments’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-350	Closed	-$16K	–	946
2015 Q3	$16K	Buy	+350	New	+$19.6K	﹤0.01%	660
2015 Q2	–	Sell	-350	Closed	-$19K	–	890
2015 Q1	$19K	Hold	350	–	–	﹤0.01%	662
2014 Q4	$18K	Hold	350	–	–	﹤0.01%	690
2014 Q3	$16K	Hold	350	–	–	﹤0.01%	736
2014 Q2	$15K	Hold	350	–	–	﹤0.01%	707
2014 Q1	$14K	Hold	350	–	–	﹤0.01%	656
2013 Q4	$13K	Sell	350 -150	-30%	-$5.38K	﹤0.01%	695
2013 Q3	$18K	Hold	500	–	–	﹤0.01%	563
2013 Q2	$14K	Buy	+500	New	+$14.2K	﹤0.01%	561

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Summer Investments's PBE Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2015, closing a stake of 350 shares — an estimated $16K sold.

Pinnacle Summer Investments first reported a position in PBE in Q2 2013 and held it in 9 quarters. The position peaked at $19K in Q1 2015. 86 funds tracked by Wall St. Rank hold PBE as of Q4 2015.

Pinnacle Summer Investments reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2015 after selling out during the quarter.
Pinnacle Summer Investments sold 350 Invesco Biotechnology & Genome ETF shares in Q4 2015, an estimated $16K.
Pinnacle Summer Investments first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 9 quarters.
Pinnacle Summer Investments's Invesco Biotechnology & Genome ETF position peaked at $19K in Q1 2015.
86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.